Howell N, Belli T A, Zaczkiewicz L T, Belli J A
Cancer Res. 1984 Sep;44(9):4023-9.
An Adriamycin-resistant Chinese hamster V79 line was isolated previously in this laboratory. There was about a 5-fold increase in Adriamycin resistance in this mutant as determined from survival curve measurements. Using this low-level Adriamycin-resistant mutant, a cell line with a high level of resistance was isolated after a multistep selection process culminating in continuous growth of the cells in medium containing 5.0 micrograms Adriamycin/ml. These cells are about 3000 times more resistant towards the cytotoxic effects of Adriamycin than is the parental V79 line. This high-level resistance phenotype is unstable and lost upon culture in the absence of drug. The highly resistant cells also showed increased cross-resistance to actinomycin D, Colcemid, and vincristine compared to the low-level resistant cells. Cytogenetic studies showed that these mutant cells contained increased numbers of double minute chromosomes and that the number of double minutes decreased proportionately with the reduction of Adriamycin resistance in cultures changed to drug-free medium. Adriamycin uptake assays demonstrated that there was a further decrease in net uptake relative to the low-level resistant mutant.
本实验室先前分离出了一株对阿霉素耐药的中国仓鼠V79细胞系。根据存活曲线测量结果,该突变体对阿霉素的耐药性增加了约5倍。使用这种低水平阿霉素耐药突变体,经过多步筛选过程,最终在含有5.0微克阿霉素/毫升的培养基中使细胞持续生长,从而分离出了具有高水平耐药性的细胞系。这些细胞对阿霉素细胞毒性作用的耐药性比亲本V79细胞系高约3000倍。这种高水平耐药表型不稳定,在无药物培养时会丧失。与低水平耐药细胞相比,高耐药细胞对放线菌素D、秋水仙酰胺和长春新碱的交叉耐药性也增加。细胞遗传学研究表明,这些突变细胞含有数量增加的双微体染色体,并且在更换为无药物培养基的培养物中,双微体的数量随着阿霉素耐药性的降低而相应减少。阿霉素摄取试验表明,相对于低水平耐药突变体,净摄取量进一步降低。